Xiangyang Wang

Xiangyang Wang serves as Chief Technology Officer at ArriVent Biopharma. ArriVent Biopharma operates in the research sector with approximately 60.0 employees. The company is headquartered in Rockville, Maryland. ArriVent Biopharma generates annual revenue of 1500000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 2,221 executive contacts are available in Maryland.
• • Our database includes 201,467 c suite-level executives.

Outlook Microsoft Office 365 Adobe Marketing Cloud Google Font API Google Tag Manager reCAPTCHA WordPress.org Mobile Friendly Remote AI

biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical drug development clinical trials oncology therapeutics egfr inhibitors antibody drug conjugates cancer treatment firmonertinib novel medicines regulatory approval treatment advances patient access expanded access policy strategic collaborations global development difficult-to-treat diseases innovation in biotech differentiated medicines clinical research partnerships commercialization drug candidate pipeline development cancer biology safety profiles efficacy profiles fda designation advanced cancers research collaborations anti-cancer therapies solid tumors preclinical studies phase 1 trials phase 2 trials phase 3 trials mutational targeting biologic rationale global health impact investment opportunities therapeutic development life sciences patient-centered care drug discovery pharmaceutical partnerships oncogene dependency market access strategies clinical efficacy health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Xiangyang Wang in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at ArriVent Biopharma.

Xiangyang Wang's Position in the MessageCEO Database

• •Xiangyang Wang is 1 of 1 verified executive contact we track at ArriVent Biopharma.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •2,100 verified executive contacts in Maryland are in the database.
• •12 verified contacts work at research companies in the 60.0 employee range (same size as ArriVent Biopharma).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated August 2026.

How do I reach Xiangyang Wang directly?

Xiangyang Wang's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at ArriVent Biopharma. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Xiangyang Wang work for?

Xiangyang Wang is Chief Technology Officer at ArriVent Biopharma, a company in the research sector with 60.0 employees. The company is based in Rockville, Maryland.

Can I pitch or sell to Xiangyang Wang?

As Chief Technology Officer at ArriVent Biopharma, Xiangyang Wang is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Xiangyang Wang directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Xiangyang Wang in?

Xiangyang Wang works in the research industry as Chief Technology Officer at ArriVent Biopharma. MessageCEO provides verified contact information for executives across all major industries.

Is Xiangyang Wang's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Xiangyang Wang's profile is kept up-to-date with the latest available information.

Last updated: August 14, 2026